$360B Women's Health Ghost Market Report

For our final deal of our Top 10 Deals of 2023 series, we look at a notable women's health acquisition in generic medicines. This deal proves pharmaceutical players’ appetite for women’s health products and bodes well for future innovation in the field.

This week we review the reproductive health and obstetrics landscape following CooperCompanies’ acquisition of Cook Medical’s OBGYN product line.

This week we explore the acquisition of Bonafide Health, a significant deal in the Menopause space. This strategic move marks a pivotal shift, bringing much-needed attention to an often overlooked area of women’s health.

Amboy Street Ventures (ASV) is excited to announce its latest investment in Granata Bio.

This week we assess the acquisition of Binx Health, an at-home STI testing company and consider similar pioneers in the sexual health space.

This week we discuss what the acquisition of Intrarosa means for the industry and consider similar pioneers in the women’s health space.

This week we acknowledge Evernow’s fundraising success and highlight the positive impact they are making in the field of women’s health.

This week we discuss what the acquisition of XinThera means for the industry and consider similar pioneers in the women’s health space.

This week we reflect on the remarkable trajectory of Kindbody’s growth, applauding their substantial fundraising achievements, underscoring the positivity it brings to the women’s health sector.